Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials - Wikidata - wikimedia - TriplyDB

Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials

Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials

http://www.wikidata.org/entity/Q34614873

about

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis Hypothyroidism and its rapid correction alter cardiac remodeling Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use B-type natriuretic peptide-guided treatment for heart failure.The potential value of integrated natriuretic peptide and echo-guided heart failure management.Protocol for a systematic review and individual participant data meta-analysis of B-type natriuretic peptide-guided therapy for heart failure.Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure.Charting a roadmap for heart failure biomarker studies.Aerobic exercise effect on prognostic markers for systolic heart failure patients: a systematic review and meta-analysis.Does B-type natriuretic peptide-guided therapy improve outcomes in patients with chronic heart failure? A systematic review and meta-analysis of randomized controlled trials.The human cardiac and skeletal muscle proteomes defined by transcriptomics and antibody-based profiling.1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure.Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.A review on B-type natriuretic peptide monitoring: assays and biosensors Neuro-hormonal effects of physical activity in the elderly.Effects of exercise on cardiovascular performance in the elderly.Heart failure in patients presenting with dyspnoea to the emergency department in the Asia Pacific region: an observational study.Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin.Old and new tools to assess dyspnea in the hospitalized patient.Natriuretic peptide-guided heart failure management.Natriuretic peptides in cardiovascular diseases: current use and perspectives Effects of exercise training on cardiovascular adrenergic system.B-type natriuretic peptide-guided therapy: a systematic review.NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure.Prognostic value of galectin-3 in patients with heart failure.Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014).The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.Galectin-3 correlates with arrhythmogenic right ventricular cardiomyopathy and predicts the risk of ventricular -arrhythmias in patients with implantable defibrillators.Can Natriuretic Peptides be Used to Guide Therapy?ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure.Association between matrix metalloproteinase-9 and worsening heart failure events in patients with chronic heart failure.Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?In search of an efficient strategy to monitor disease status of chronic heart failure outpatients: added value of blood biomarkers to clinical assessment.The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent Heart Failure and Death in Patients with Stable Coronary Artery Disease: The Heart and Soul Study.Brain natriuretic peptide-guided management of chronic heart failure: first do no harm.Pharmacogenomics of the Natriuretic Peptide System in Heart Failure.Heart failure readmissions.Saliva and plasma levels of cardiac-related biomarkers in post-myocardial infarction patients.

P2860

Q27012693-23B466FB-62C8-4BB9-B108-E25803551ABE Q27339180-A4CFFAE8-0F4A-42B7-ABF1-3C0975BDB5CA Q28081433-292F5301-8B7A-4A4E-8455-7D21AB14FBDB Q30238936-227D412F-97B0-4114-B87D-3DA8DF6A5DD0 Q30434020-97B47DF5-8A71-4876-8E53-EDCC625274A1 Q33960469-19387BA3-B3D4-4793-978F-A178AD8115C1 Q34250674-2962658C-8839-45BF-BFF2-12585F8206DF Q34324771-C1F10971-522C-4A74-8F20-121A244DAAF8 Q34324812-5A1760DB-DF5A-467E-9848-0CC6908F96A8 Q35017888-75835D67-B368-4948-93FD-F16AD5F3CA66 Q35179984-825F1BBA-88B2-4D2E-922F-0995BA585E45 Q35673626-533D8D99-3AEF-498F-8DF0-F39B023F1D9A Q35755817-536D2D1A-FF99-41C4-A26C-E572CF04736B Q35792547-F72BC5D5-9404-44CA-88EF-A105038BB70F Q37171880-DC9089FC-C9EB-417A-AA01-FB02D13B0EE4 Q37404953-9087773B-0F71-4706-B936-AFC8820FFFDA Q37594289-6B062F80-BFE7-4E84-967B-D43CFC9E8BFD Q37681401-0F13BDE1-A20E-4410-9153-F7C105E8DAA0 Q38096829-C693E12F-0462-4242-ABCD-729D2655DB4C Q38114009-0F97DBFA-9D1F-4CA3-840E-8224CBE1CAE3 Q38161695-F7A06022-2D2F-4551-B2C3-CDC778CC052A Q38162429-584C7A80-7372-4828-9725-B0A37EFEB147 Q38172127-01E226CB-F526-42DA-85BC-C7C9C113E4E3 Q38235223-3CA353B7-F44E-4939-9C45-09DE1CE9C3A8 Q38378152-280C95BF-C35F-489E-B9DB-DB36D039E6AF Q38424871-CADCD460-C838-4C28-9500-276AC5BAED85 Q38471023-A4601B3E-1A1A-43E6-9C60-9C811B8B845A Q38546917-99DDDF8D-BD1E-4F7D-9C44-C08131742DD5 Q38551693-1F28046F-5523-4884-A64D-A5982B81D38F Q38680570-A9B3C485-4F09-4413-9C98-92D34D4D4179 Q38967512-D088A234-23A2-4F7D-83F1-7FE4446C7CA1 Q41083010-96730CB4-F885-44B2-8CD9-FD9FBC5061C0 Q41239335-AF8489D2-2A24-4A4D-B88B-6699484D957A Q41534613-4AFBA1CB-8B71-459E-95B8-668D2B940CDE Q42646632-DE2E5D90-5F21-4131-BCD3-7A4581C2002D Q44540336-6097C7E0-FEA5-45CF-8BF5-C00770E69EFC Q44566168-F5D720C1-7B64-4244-98BF-334ACAD1D401 Q47596916-81A865B6-C9CD-4B33-948C-20A96B378157 Q48003695-86BA07E9-5BA5-48D9-8322-0C06AA2FAA33 Q48217947-D8C6A64C-48EC-46C6-BF56-2769470E82E5

P2860

Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials

http://www.wikidata.org/entity/Q34614873

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Natriuretic peptide-guided the ...... tients in 12 randomized trials

@ast

Natriuretic peptide-guided the ...... tients in 12 randomized trials

@en

Natriuretic peptide-guided the ...... tients in 12 randomized trials

@nl

type

label

Natriuretic peptide-guided the ...... tients in 12 randomized trials

@ast

Natriuretic peptide-guided the ...... tients in 12 randomized trials

@en

Natriuretic peptide-guided the ...... tients in 12 randomized trials

@nl

prefLabel

Natriuretic peptide-guided the ...... tients in 12 randomized trials

@ast

Natriuretic peptide-guided the ...... tients in 12 randomized trials

@en

Natriuretic peptide-guided the ...... tients in 12 randomized trials

@nl

P1433

Q34614873-51FAEB97-8390-43D3-85C7-6D301B07434C

P1476

Q34614873-D8D0D7A2-5F44-41CD-A928-6E435B8DD50A

P2093

Q34614873-56A478BF-FDC6-4BCF-A6B2-CDAB5EC9A76B

Q34614873-59CA0907-8999-4E0E-9DF4-184C83830C10

Q34614873-8ADB9FD5-F959-4853-B23C-272FFE80FF66

Q34614873-8C382074-96AE-40FE-8D42-1C92AA92CF5C

P2860

Q34614873-0C8203D6-71AB-4111-B07C-821D9C501BAD

Q34614873-16F43E57-76FB-4D54-9D68-FE592D79291E

Q34614873-1AA20A76-5E67-401B-8026-1108E263581A

Q34614873-2B170856-A340-4711-AF87-BBFB11A7895D

Q34614873-2F0E4E2C-A258-465F-A611-CF4E4FBDCB26

Q34614873-320DA63B-1367-4DB0-8FA7-566B676669BA

Q34614873-3B616FE4-C6D9-4E5A-8D0D-A65B9911152C

Q34614873-3D2CB2E4-D47C-48B7-8BC9-AF58A76A1B09

Q34614873-3EA4CDE6-7EA0-4D4C-A9A5-CA94CF5E6305

Q34614873-3F7BE223-6DE2-48C9-8223-13371EC04AE9

P304

Q34614873-B824C972-B855-41CF-9367-4162EF29AAD0

P31

Q34614873-3FBE8B71-C034-4348-814A-956761F21119

Q34614873-e9828629-50ec-45a4-af31-f3741d0037cb

P356

Q34614873-BD8D1D9C-9873-4E18-88EF-6AA837D4498B

P407

Q34614873-4C21F891-0374-480F-8B13-66CF457DCB10

P433

Q34614873-9B6B7D5A-98D9-4F97-A5A1-36D622238587

P478

Q34614873-8D10C71A-E602-4E96-A58C-52256DAD3DA2

P50

Q34614873-12BDCFA6-A52C-4F8B-AE4D-AD276D560591

Q34614873-33FC6309-7B69-4EBD-9F68-6AD8839F00F6

Q34614873-80B8CC15-D94E-4F67-B7E3-87BA5AF01EB9

Q34614873-DC11CE37-B559-4D28-AEA1-65146F5E89EF

P577

Q34614873-998B86C8-FF94-4413-ADC3-7736A75433AB

P5875

Q34614873-2C36A8F9-B24E-4F74-8CBF-92018B08D42E

P698

Q34614873-604D1192-69B9-4853-9622-FDCEE2F8B4C2

P921

Q34614873-016163FD-38F1-41F1-83BB-41FE4FA07F7D

Q34614873-BC7848C5-F9F5-4018-B574-5D6102202F93

P932

Q34614873-D0FC683C-893D-4578-9FBA-76CC4F50605D

P356

JOURNAL.PONE.0058287

P1433

P1476

Natriuretic peptide-guided the ...... tients in 12 randomized trials

@en

P2093

Francesco Gambardella

http://www.w3.org/2001/XMLSchema#string

Maria Prastaro

http://www.w3.org/2001/XMLSchema#string

Pasquale Perrone-Filardi

http://www.w3.org/2001/XMLSchema#string

Santo Dellegrottaglie

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Comparison of two methods to detect publication bias in meta-analysis

Self-management counseling in patients with heart failure: the heart failure adherence and retention randomized behavioral trial

Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population

BNP or NTproBNP? A clinician's perspective.

Biomarker guided therapy for heart failure: focus on natriuretic peptides.

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.

P304

e58287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0058287

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Gianluigi Savarese

P577

2013-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235886455

http://www.w3.org/2001/XMLSchema#string

P698

23472172

http://www.w3.org/2001/XMLSchema#string

P921

P932

3589263

http://www.w3.org/2001/XMLSchema#string